Anne M. Finucane's most recent trade in Williams-Sonoma, Inc. was a trade of 144 Deferred Stock Units done . Disclosure was reported to the exchange on May 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 144 | 144 | - | - | Deferred Stock Units | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 109 | 109 | - | - | Deferred Stock Units | |
CVS Health Corp | Anne M. Finucane | Director | Gift of securities by or to the insider at price $ 56.86 per share. | 05 Dec 2024 | 2,665 | 4,567 (0%) | 0% | 56.9 | 151,532 | Common Stock |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2024 | 820 | 6,904 (0%) | 0% | 0 | Common Stock | |
CVS Health Corp | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 2,200 | 12,173 | - | - | Deferred Stock Units | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 171 | 171 | - | - | Deferred Stock Units | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 148 | 148 | - | - | Deferred Stock Units | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 1,468 | 0 | - | - | Restricted Stock Units | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 1,468 | 3,832 (0%) | 0% | 0 | Common Stock | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 712 | 712 | - | - | Restricted Stock Units | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 30 | 3,862 (0%) | 0% | 0 | Common Stock | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 30 | 0 | - | - | Restricted Stock Units | |
CVS Health Corp | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 2,184 | 9,747 | - | - | Share Credits | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 81 | 81 | - | - | Deferred Stock Units | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 110 | 2,364 (0%) | 0% | 0 | Common Stock | |
CVS Health Corp | M. Finucane Anne | Director | Gift of securities by or to the insider at price $ 74.28 per share. | 07 Dec 2023 | 3,450 | 7,232 (0%) | 0% | 74.3 | 256,266 | Common Stock |
Williams-Sonoma, Inc. | Finucane M. Anne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 30 | 30 | - | - | Restricted Stock Units | |
CVS Health Corp | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 69.13 per share. | 15 Nov 2023 | 1,925 | 10,682 (0%) | 0% | 69.1 | 133,075 | Common Stock |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2023 | 145 | 2,254 (0%) | 0% | 0 | Common Stock | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 151 | 2,109 (0%) | 0% | 0 | Common Stock | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2023 | 1,468 | 1,468 | - | - | Restricted Stock Units | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2023 | 1,328 | 1,958 (0%) | 0% | 0 | Common Stock | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2023 | 1,328 | 0 | - | - | Restricted Stock Units | |
CVS Health Corp | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 69.31 per share. | 18 May 2023 | 1,437 | 8,757 (0%) | 0% | 69.3 | 99,598 | Common Stock |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 175 | 630 (0%) | 0% | 0 | Common Stock | |
CVS Health Corp | Anne M. Finucane | Director | Gift of securities by or to the insider at price $ 97.35 per share. | 18 Nov 2022 | 800 | 28,964 (0%) | 0% | 97.4 | 77,880 | Common Stock |
CVS Health Corp | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 94.93 per share. | 17 Nov 2022 | 1,428 | 7,320 (0%) | 0% | 94.9 | 135,560 | Common Stock |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 1,328 | 1,328 | - | - | Restricted Stock Units | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 455 | 0 | - | - | Restricted Stock Units | |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 455 | 455 (0%) | 0% | 0 | Common Stock | |
CVS Health Corp | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 97.99 per share. | 11 May 2022 | 1,384 | 5,892 (0%) | 0% | 98.0 | 135,618 | Common Stock |
CVS Health Corp | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 92.73 per share. | 17 Nov 2021 | 1,314 | 1,314 (0%) | 0% | 92.7 | 121,847 | Common Stock |
Williams-Sonoma, Inc. | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2021 | 455 | 455 | - | - | Restricted Stock Units | |
CVS Health Corp | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 84.27 per share. | 13 May 2021 | 1,446 | 1,446 (0%) | 0% | 84.3 | 121,854 | Common Stock |
CVS Health Corp | Anne M. Finucane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2020 | 1,836 | 9,959 | - | - | Share Credits |